Longitudinal studies should be conducted to evaluate whether the extracellular IA-2 immunoreactivity associated to low-grade inflammation is then able to trigger a “spreading” of autoimmunity to intracellular epitopes, causing a more severe autoimmune disease in predisposed subjects or in the presence of precipitating factors. The gene discussed is PTPRN; the disease is Autoimmunity.